49
HEMATOLOGIC OBSERVATIONS
Table 4.2.—Group I Rongelap Mean Blood Counts by Day and by Age
P. E. Day
Be
WBC.
(x10)
<5
|
5
NEUTROPHILES
(x 10)
<5
3. 7__-- 2 ---------10___------------.-
90
4.9
66
}
82; 64
62 | wee
T1385
15__.-------------18___-_--------.--
5.9
67
65°
72,
12___._-----------
22__.-_-----------
7.0
<5
22
-ee
2.1
03
ee
17
0.1
a-16
07
--16
24
24
19
2.1
27.1
21.8
21.3
191
21.7;3.0
218/27
2.3
L7
Lil
3.5
L3
1.6
23
3.2
3.2
2.6
29
31
3.4
37
3.7
33
eee
3.6
4.6
74
#18
21
2.0
2.0
2.3
24
2.1
24
2.3
22
nee
22
2.8
41
13.2
14.1
17.9
25.5
26.8
24.6
22.1
---23.1
wen
26.2
24.4
26.6
41.2
12.9
12.3
166
22.0
209
20.6
$17.5
---182
nee
21.7
20.3
19.5
25.8
10.9]
1.9
118/15
151/17
224;09
238.2)
11
23.9;
10
21.2)/25
---17
202/05
wees
ee
24.7
_-23.2)
1.4
27.6|),07
365);
2.0
16
09
16
O9
Ld
1.0
1.6
OL
09
ee
.-11
1.3
2.0
18
34
2.6
05
14
11
08
wee
0.3
3.4
wee
2.5
6.7
95
13
22
2.2
10
08
085
0.7
wee
0.6
19
eee
1.6
2.8
4.7
3.9
5.3
3.8
3.3
2.6
3.3
38.5
3.5
3.6
40
eee
42
48
48
400
(p<0.01) developed during the 7th and 8th
weeks, and values remained at approximately
=, 300
™
mainder of the initial observation period. No
additional recovery had occurred by the 6th
month. At 12 months the counts were higher
but still below the control range. The pattern
.
of platelet counts in the male groups was remarkably similar to that noted for the females.
Counts of the lower age group, males, were
consistently higher than those of the adult
group in absolute counts; but consistently lower
as percent of control.
E
B 500
A second decrease in the platelet count
70 percent of the control groups during the re-
Ages
| wee ---
26 21
ing this, the platelet count fell reaching a low
i
.
of approximately
30 percent of control
value
during the 4th week. The platelet count rose
during the 5th and 6th weeks and reached the
value noted for the initial counts on the 10th
day.
All
>5
21 27
>10
168
146
<5
(x 102
<5
61
3.0
7.8
40
6.2
3.1
6.4
3.0
5.2
20
5.8
26
5.6 ; -26
6.0
3.5
6.0
3.9
6.5
3.8
eee
wee
6.6
46
8&1
4.7
97; 48
<0
EOsINOPHILES
>5
41
47
>5
(x 10)
(F)
----/08
eee
eee
221/29
32
324
43 5.0
MONOCYTES
(x 104)
(M)
---fee
22.7
18
w-2.6
7.4,
PLATELETS
(M)
---aw--28.2
47
oee
45
5.9 63, 35 39
26_-_------------5.7
30__--- e+e ee.
7.6
33___..----------6.5
39__.- eee eee
6.7
43__--_ 2-2 eee | §2
47___2 2
5.9
51_.--..---------6.7
56__2------------7.0
63___-.----------7.7
70_._-----------7.6
74.0 2222- ee
eee
185__--_---------85
400_.-_-_-.--.----- 10.1
Controls Group A__| 13.2
LYMPHOCYTES
42 54]
152/19 20;
Lo 19
23
L8
A
tT T_T
T7*
CONTROLS
GROUP A, MALE.
<ION6)
|
GROUP ALFEMALE, ALL acesicey —
1——l
1
r
crelete
*
bs
FASMALE >10(18) —prSx
AH .
* \
A!
pe
r
100 0
10
@ MALES,<IO(I1)
1
A MALES,>10{1B)
°
| *: T AGES 33)
Ah 185
50
60
70
20
30.040
POST EXPOSURE DAY
FIGurRE 4.4—Seriail platelet changes in those less than
Id years and greater than 10 years of age of Group
I (Rongelap).